Addiction

Alleva Recognized in Software Advice FrontRunners for HIPAA Compliance Software Report 2024

LAGUNA NIGUEL, Calif., July 2, 2024 /PRNewswire/ -- Alleva, a premier provider of electronic medical record (EMR) software solutions tailored…

5 months ago

Hazelden Betty Ford Foundation Announces Lineup for 75th Anniversary Gala

Rob Lowe to EmceeCenter City, Minnesota--(Newsfile Corp. - July 1, 2024) - On Friday, September 13, Hazelden Betty Ford Foundation,…

5 months ago

Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes

SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…

5 months ago

Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment

Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

5 months ago

I’m Lonely, Inc. Launches Revolutionary Dating App to Foster Genuine In-Person Connections

HOUSTON, June 27, 2024 /PRNewswire/ -- I'm Lonely, Inc. is thrilled to announce the launch of its innovative dating app, designed…

5 months ago

Monte Rosa Therapeutics Provides Development Progress Updates on MRT-2359 and MRT-6160

Ongoing Phase 1/2 Study of MRT-2359 for MYC-driven solid tumors demonstrates favorable safety and pharmacodynamic profile dosing 0.5 mg using…

5 months ago

Safe Supply Streaming Corp. Announces Resignation of Board Member

Toronto, Ontario--(Newsfile Corp. - June 21, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or…

5 months ago

Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder

AD04 reduced heavy drinking days among heavy drinking individuals with alcohol use disorder and a specific genetic profile, as identified…

5 months ago

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia

HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced…

5 months ago

New Avenues Rehab Center in Virginia Offers Hope and Healing

Avenues Recovery Center Opening in Norfolk Will Change the Landscape of Mental Health Care in VirginiaNORFOLK, VA / ACCESSWIRE /…

5 months ago